Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Curing bladder cancer by replacing corrupted urothelium with differentiated hES cells

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Research Objective The goal of the proposed research is to use human embryonic stem cells to generate bladder epithelial progenitor cells that can be used to replace a cancerous bladder…

Continue ReadingCuring bladder cancer by replacing corrupted urothelium with differentiated hES cells

Purification of Human Hematopoietic Stem Cells (HSCs) for Clinical Stem Cell Transplantation

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Translational Candidate Two new monoclonal antibodies anti-CD34 and anti-CD90, and protocols to purify cancer-free and/or T cell free human HSC for clinical transplantation. Area of Impact The development of hematopoietic…

Continue ReadingPurification of Human Hematopoietic Stem Cells (HSCs) for Clinical Stem Cell Transplantation

A Rapid Clinical Digital Patient-derived Organoid to Guide Breast Cancer Treatment Decision

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Translational Candidate The digital patient organoid (DPO) assay is a microfluidic miniature organoid technology that allows high-throughput drug testing. Area of Impact Our functional DPO assay will guide personalized therapy…

Continue ReadingA Rapid Clinical Digital Patient-derived Organoid to Guide Breast Cancer Treatment Decision

GlyTR2 CAR T cell translation: safe pan-cancer killing via velcro-like density-dependent targeting of cancer glycans

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Continue ReadingGlyTR2 CAR T cell translation: safe pan-cancer killing via velcro-like density-dependent targeting of cancer glycans

FM-IL2 CAR T cells for Pancreatic Cancer

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Continue ReadingFM-IL2 CAR T cells for Pancreatic Cancer

Development of an off-the-shelf iPSC derived CAR T cell therapy for the treatment of solid tumors

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Continue ReadingDevelopment of an off-the-shelf iPSC derived CAR T cell therapy for the treatment of solid tumors

A Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral Vectors

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Continue ReadingA Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral Vectors

A novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Continue ReadingA novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies

Targeting pancreatic cancer with Allogeneic Off-the-Shelf PSCA-CAR NK cells

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Translational Candidate PSCA-CAR_sIL15 NK cells derived from CD34(+) umbilical cord blood hematopoietic stem cells Area of Impact patients with metastatic pancreatic cancer or other cancers that also highly express PSCA…

Continue ReadingTargeting pancreatic cancer with Allogeneic Off-the-Shelf PSCA-CAR NK cells

Combating Ovarian Cancer with Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy

  • Post author:
  • Post published:June 14, 2026
  • Post category:

Translational Candidate stem cell-based off-the-shelf CAR-NKT cells Area of Impact ovarian cancer (OC) Mechanism of Action The proposed cell therapy candidate, AlloMCAR-NKT cells, can directly kill OC tumor cells through…

Continue ReadingCombating Ovarian Cancer with Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy
  • Go to the previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 18
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us